Hirokazu Tanino – Google Scholar
2020
Antibody-Conjugated Signaling Nanocavities Fabricated by Dynamic Molding for Detecting Cancers Using Small Extracellular Vesicle Markers from Tears. Takeuchi T, Mori K, Sunayama H, Takano E, Kitayama Y, Shimizu T, Hirose Y, Inubushi S, Sasaki R, Tanino H. J Am Chem Soc. 2020 Apr 8;142(14):6617-6624. doi: 10.1021/jacs.9b13874. Epub 2020 Mar 20. PMID: 32155056
Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients. Inubushi S, Kawaguchi H, Mizumoto S, Kunihisa T, Baba M, Kitayama Y, Takeuchi T, Hoffman RM, Tanino H, Sasaki R. Anticancer Res. 2020 Jun;40(6):3091-3096. doi: 10.21873/anticanres.14290. PMID: 32487603
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study. Yamamoto Y, Yamashiro H, Toh U, Kondo N, Nakamura R, Kashiwaba M, Takahashi M, Tsugawa K, Ishikawa T, Nakayama T, Ohtani S, Takano T, Fujisawa T, Toyama T, Kawaguchi H, Mashino K, Tanino Y, Morita S, Toi M, Ohno S. Breast Cancer. 2020 Jul 26. doi: 10.1007/s12282-020-01138-4. Online ahead of print. PMID: 32715420
Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy. Murata T, Hozumi C, Hiroshima Y, Shimoya K, Hongo A, Inubushi S, Tanino H, Hoffman RM. In Vivo. 2020 Nov-Dec;34(6):3241-3245. doi: 10.21873/invivo.12160. PMID: 33144429
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy. Narui K, Ishikawa T, Oba MS, Hasegawa Y, Kaise H, Kawate T, Yamada A, Yamada K, Suzuki Y, Niikura N, Kohno N, Kimoto T, Sugae S, Kosaka Y, Miyashita M, Okamura T, Shimizu D, Tanino H, Tanabe M, Morita S, Endo I, Tokuda Y. Surg Oncol. 2020 Dec;35:447-452. doi: 10.1016/j.suronc.2020.10.002. Epub 2020 Oct 6. PMID: 33045629
A Universal Gelfoam 3-D Histoculture Method to Establish Patient-derived Cancer Cells (3D-PDCC) Without Fibroblasts from Patient-derived Xenografts. Yamamoto J, Sugisawa N, Hamada K, Nishino H, Miyake K, Matsuyama R, Inubushi S, Tanino H, Bouvet M, Endo I, Hoffman RM. Anticancer Res. 2020 Dec;40(12):6765-6768. doi: 10.21873/anticanres.14699. PMID: 33288569
Chyle leakage after axillary node sampling in a patient with breast cancer: a case report. Kohno N, Kimoto T, Okamoto A, Tanino H. Surg Case Rep. 2020 Jun 1;6(1):119. doi: 10.1186/s40792-020-00885-y. PMID: 32488538 Free PMC article.
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model. Yamamoto J, Murata T, Sugisawa N, Higuchi T, Tashiro Y, Nishino H, Inubushi S, Sun YU, Lim H, Miyake K, Shimoya K, Nomura T, Kurebayashi J, Tanino H, Hozumi C, Bouvet M, Singh SR, Endo I, Hoffman RM. Anticancer Res. 2020 May;40(5):2475-2479. doi: 10.21873/anticanres.14217.PMID: 32366391
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib. Yamamoto J, Murata T, Tashiro Y, Higuchi T, Sugisawa N, Nishino H, Inubushi S, Sun YU, Lim H, Miyake K, Hongo A, Nomura T, Saitoh W, Moriya T, Tanino H, Hozumi C, Bouvet M, Singh SR, Endo I, Hoffman RM. Anticancer Res. 2020 May;40(5):2509-2514. doi: 10.21873/anticanres.14221. PMID: 32366395
BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study. Kosaka Y, Yamamoto Y, Tanino H, Nishimiya H, Yamamoto-Ibusuki M, Hirota Y, Iwase H, Nakamura S, Akashi-Tanaka S. Diagnostics (Basel). 2020 Feb 21;10(2):119. doi: 10.3390/diagnostics10020119. PMID: 32098267 Free PMC article.
2019
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment. Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N; JONIE STUDY GROUP. Anticancer Res. 2019 Aug;39(8):4305-4314. doi: 10.21873/anticanres.13596. PMID: 31366522 Clinical Trial.
2018
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancer. Kosaka Y, Minatani N, Tanaka Y, Shida A, Kikuchi M, Nishimiya H, Waraya M, Katoh H, Sato T, Sengoku N, Tanino H, Yamashita K, Watanabe M. Mol Clin Oncol. 2018 Nov;9(5):566-574. doi: 10.3892/mco.2018.1716. Epub 2018 Sep 13. PMID: 30402236 Free PMC article.
Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer. Hoffman RM, Tanino H. Methods Mol Biol. 2018;1760:93-100. doi: 10.1007/978-1-4939-7745-1_10. PMID: 29572797
2017
Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer. Kikuchi M, Katoh H, Waraya M, Tanaka Y, Ishii S, Tanaka T, Nishizawa N, Yokoi K, Minatani N, Ema A, Kosaka Y, Tanino H, Yamashita K, Watanabe M. Cancer Lett. 2017 Jan 1;384:70-78. doi: 10.1016/j.canlet.2016.10.017. Epub 2016 Oct 15. PMID: 27756570
Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer. Ishikawa T, Akazawa K, Hasegawa Y, Tanino H, Horiguchi J, Miura D, Hayashi M, Kohno N. J Surg Res. 2017 Dec;220:46-51. doi: 10.1016/j.jss.2017.05.066. Epub 2017 Jul 26. PMID: 29180210 Clinical Trial.
Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015. Yamamura J, Masuda N, Yamamoto D, Tsuyuki S, Yamaguchi M, Tanaka S, Tsurutani J, Tokunaga S, Yoshidome K, Mizutani M, Aono T, Ooe A, Tanino H, Matsunami N, Yasojima H, Nakayama T, Nishida Y. Chemotherapy. 2017;62(5):307-313. doi: 10.1159/000475879. Epub 2017 Jun 13. PMID: 28605730 Clinical Trial.
2016
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Tanino H, Kosaka Y, Nishimiya H, Tanaka Y, Minatani N, Kikuchi M, Shida A, Waraya M, Katoh H, Enomoto T, Sengoku N, Kajita S, Hoffman RM, Watanabe M. PLoS One. 2016 Dec 9;11(12):e0165721. doi: 10.1371/journal.pone.0165721. eCollection 2016. PMID: 27935989 Free PMC article.
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. Kikuchi M, Yamashita K, Waraya M, Minatani N, Ushiku H, Kojo K, Ema A, Kosaka Y, Katoh H, Sengoku N, Enomoto T, Tanino H, Sawanobori M, Watanabe M. Oncotarget. 2016 Jan 12;7(2):1741-53. doi: 10.18632/oncotarget.6480. PMID: 26646320 Free PMC article.
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. Minatani N, Waraya M, Yamashita K, Kikuchi M, Ushiku H, Kojo K, Ema A, Nishimiya H, Kosaka Y, Katoh H, Sengoku N, Tanino H, Sidransky D, Watanabe M. PLoS One. 2016 Jan 19;11(1):e0144862. doi: 10.1371/journal.pone.0144862. eCollection 2016. PMID: 26785325 Free PMC article.
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy. Kosaka Y, Tanino H, Sengoku N, Minatani N, Kikuchi M, Nishimiya H, Waraya M, Katoh H, Enomoto T, Sato T, Kuranami M, Watanabe M. Support Care Cancer. 2016 Mar;24(3):1405-11. doi: 10.1007/s00520-015-2905-4. Epub 2015 Sep 8. PMID: 26349772 Free PMC article. Clinical Trial.
2015
Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study). Hasegawa Y, Tanino H, Horiguchi J, Miura D, Ishikawa T, Hayashi M, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Akazawa K, Kohno N; JONIE Study Group. PLoS One. 2015 Dec 3;10(12):e0143643. doi: 10.1371/journal.pone.0143643. eCollection 2015. PMID: 26633806 Free PMC article. Clinical Trial.
